EDAP TMS SA Message Board

termi0209 11 posts  |  Last Activity: Jun 12, 2016 5:56 AM Member since: Dec 25, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • termi0209 by termi0209 Jun 12, 2016 5:56 AM Flag

    Too much negativity here..
    Really we don´t have the best management, but they could be worst, that´s for sure..
    I don´t think that is a good idea for longs to critizise your own company all the time, we need new investors not to scare away them...pero esto es un foro y cada uno que escriba lo que quiera, of course., but
    we have a PROFITABLE company and I think that they are doing a great job...in litho division..
    Obviously the offering has killed the S.P for now , and I didn´t like the offering but what I see now is a profitable company with a healthy balance:

    - strong growth in last two quarters= +61%,
    - M.K= x only 2 revenues( considering last two Q),
    - reasonable target of 45-50 m € for this year + 5-6 m O.P
    -1 $ in cash
    - the biggest catalyst in edap history´s in 3-4 months ??, + results phase 2 b liver cancer soon.

    We have seen big movements with approvals:
    7 $ before i-move
    6 $ before adcom
    6 $ before AB ..... so 3,5 $ before/ after Focal-1????!!!! NI DE COÑA!!!!
    By the way, we had a big day with approval in Canada, volume 8 m, + 60 % intraday..

    At this level edap es una MIERDA..but it will change once edap breaks the big resistance at 3,55-3,60 $
    Two years ago, like now, edap couldn´t break 3,55-3,6 , two months before adcom, edap broke the resistance and boom...

    Last year , edap couldn´t break 3,8 $...and again two months before approval broke the resistance and boom,
    so if we don´t have a delay , with the focal-1 approval in 3-4 months ... sólo un poco más de paciencia!!!
    Last year I wrote that edap was going to have a big run up before AB approval ,for this reason I bought Nov Calls y ACERTÉ. This year I think that we are going to have a big movement again in a few weeks.
    For now I´m not buying Nov calls because we have to pay +100% !!!!! in relation with 2015..
    I don´t expect double digits for now ,but at least 6 - 6,57 $ like last year, not only for speculation, because finally edap has the numbers!!

    Sentiment: Strong Buy

  • Reply to

    Prostate treatment news

    by mwalk819 Jun 10, 2016 12:37 PM
    termi0209 termi0209 Jun 10, 2016 1:02 PM Flag

    I read the news in P.M
    It was a phase 2a with only 18 patients.
    After 6 months, the injection worked in 9 patients.. In only 2 the response was complete & in 7 the response was partial.
    We have to wait a few years for the approval...and with this dates after seeing edap with fda...I don´t think that the approval is going to be easy for them...
    I

    Sentiment: Strong Buy

  • termi0209 termi0209 May 26, 2016 12:22 PM Flag

    8. There were a couple of news in 2010-11
    -EDAP To Collaborate On Use Of HIFU In Cancer Drug Delivery Following Successful Feasibility Study
    -EU gives consortium $1.6M for ultrasound-triggered drug delivery

    They were planning to start a study in 2011.. news soon...????

    Sentiment: Strong Buy

  • Reply to

    Ablatherm in Sarasota

    by termi0209 May 16, 2016 1:25 AM
    termi0209 termi0209 May 16, 2016 1:57 PM Flag

    After reading last C.C , I expect another great E.R

    "All this together shows clearly that EDAP has now reached the next level and poised for success in 2016 and well into the future. We are already experiencing growing momentum for Ablatherm devices in the United States as our Q1 activity has been intense and busy so far. Moreover, we’re also experiencing solid growth in treatment driven revenue which is indicative of the growing worldwide acceptance of HIFU. Finally, we have a strong pipeline of HIFU and lithotripsy devices at the beginning of 2016, both in the U.S. and rest of the world. This is an exciting and amazing time for EDAP that we’ve all been waiting for and that is now happening for real. We thank you all for your continued support."

    Sentiment: Strong Buy

  • termi0209 by termi0209 May 16, 2016 1:25 AM Flag

    (PRWEB) JANUARY 13, 2016
    In Search of HIFU Perfection – Is It Possible to Cure Aggressive Prostate Cancer? The answer is yes!
    HIFU Centers of America (HIFU) and Dr. Ronald Wheeler are announcing the opening of their Flagship Center of HIFU Excellence in Sarasota, Florida. Dr. Wheeler, an accomplished HIFU specialist with more than 10 years of experience, has uniquely treated more than 500 men with prostate cancer using both, the Sonablate 500 technology as well as his preferred technology … Ablatherm from EDAP-TMS.......

    (HIFUCOA´S WEB):

    HIFU Centers of America (HCOA™) began as an idea to take care of this nation’s most needy and deserving men regarding the number one health risk that they face. My vision (as a HIFU Expert) would allow many doctors to become expert in Ablatherm HIFU™, the most patient friendly and physician friendly High Intensity Focused Ultrasound (HIFU) technology in the world. WITH FDA APPROVAL, WE ARE ON THE FAST TRACK TO DEVELOP MULTIPLE CENTERS across this great land of ours. We are prepared to show any and all men interested in HIFU, why HCOA™ is the best first option related to HIFU treatment of prostate cancer.
    Unlike other technologies and other treating physicians, we have superior results using a unique treatment protocol and the Ablatherm™ treating device.......

    “I have been privileged to successfully perform over 400 HIFU procedures over the last several years outside of the US. With this approval by the FDA now official, we at HIFU Centers of America will be able to offer our non-invasive HIFU Treatment protocol which has in my opinion, proven to be more effective and safer than any other prostate cancer treatments currently available. Our hope is that many more men who suffer from prostate disease will now have a more convenient avenue to receive HIFU Treatment” Dr Wheeler continues to say “We will welcome men from all over the United States and the world to take advantage of our years of experience”....

    Sentiment: Strong Buy

  • Published Online: Friday, May 13, 2016... ( search in the website onclive)

    Results of a multi-institutional prospective study showed that treatment with unilateral high-intensity focused ultrasound (HIFU) led to eradication of all clinically significant cancer in the treated lobe for 94% of patients with early prostate cancer.

    HIFU resulted in complete ablation of all cancer in the treated lobe for 87 of 101 cases (86%) and absence of any cancer in the whole prostate (including untreated areas) in 68 cases (67%). After 2 years of follow-up, 89% of the patients remained alive without radical therapy (95% CI, 81.0-93.8). Almost 100% of patients had resolution of urinary incontinence at 12 months, and almost 80% of the men had preserved erectile function.

    “HIFU hemiablation achieved excellent local control. HIFU was associated with a low morbidity profile and an acceptable rate of complications. We confirmed preservation of quality of life,” said lead investigator Pascal Rischmann, MD, PhD, chair of urology at Rangueil University Hospital in Toulouse, France. “HIFU hemiablation for localized prostate cancer provides a reliable alternative to whole-gland radical treatment for selected patients with intermediate-risk cancer.”

    The findings, which were presented during the 2016 AUA Annual Meeting, aimed at demonstrating an intermediate role for HIFU in low- and intermediate-risk prostate cancer. Radical therapies have questionable benefits for that subgroup of patients and carry the risk of potential functional consequences, said Rischmann. Additionally, in this setting, active surveillance does not completely address the men’s needs, since there is a risk of understaging, undergrading, psychological stress, and delayed treatment.

    “Partial treatment of the gland may fill the gap between active surveillance and radical treatments,” said Rischmann. “Hemigland ablation limits the risks of morbidity and may be amenable to the approximately 20% of patients who have unilate

    Sentiment: Strong Buy

  • Reply to

    Alamance urological P.C,in North Carolina

    by termi0209 May 5, 2016 7:45 AM
    termi0209 termi0209 May 10, 2016 3:54 AM Flag

    Veremos..
    With the focal one soon, we can´t expect a lot of sales in US market yet, but hopefully more than the two sales that they have announced ,but really I expect a great E.R again ( new record revenue & O.P) for two reasons:
    1- In last times they are doing an excellent job...in litho busines.. and overall
    2-Last C.C was very postive, in 6 years following edap I don´t remeber M.O as optimistic in a C.C , "bullish" was the word that he used., and like he said they were vey busy during the Q1... Veremos
    For this reason I think that they want to report the earnings on monday again. and today they will announce that we have the earnings next monday..veremos..( espero que no sea sólo mi deseo..y no esté equivocado, por la cuenta que nos trae,y porque no me he podido resistir y he comprado más acciones a este nivel tan bajo, y tengo muchas, muchísimas acciones de edap...)

    Sentiment: Strong Buy

  • Reply to

    Alamance urological P.C,in North Carolina

    by termi0209 May 5, 2016 7:45 AM
    termi0209 termi0209 May 5, 2016 12:22 PM Flag

    Keck bought ablatherm & also they have sona.

    Sentiment: Strong Buy

  • They are using ablatherm, also the device of the company of our friend Rocky.
    So, they have not announced all the sales.

    Benefits of HIFU Using Ablatherm

    These benefits are not unique to Ablatherm, as other HIFU treatment devices also offer them. However, Ablatherm offers a few benefits unique to its device. One of these is permanent rectal wall cooling. While the focal point is the only area where tissue is heated to destruction, the ultrasound waves will heat other tissue somewhat. The rectal wall is particularly sensitive to these changes, so the Ablatherm has an active cooling and monitoring system in place.

    Ablatherm also offers real-time visualization of what is going on in the prostate gland. This allows the surgeon to adjust treatment as needed based on the body’s response. This can reduce problems like urethra-rectal fistulas that sometimes occur during prostate cancer treatment.

    The Ablatherm HIFU device allows the surgeon to place the patient in the optimum position for treatment. By laying the patient on his right side, the surgeon can minimize the influence of air bubbles and other interference while delivering treatment. This maximizes the efficiency and safety of HIFU using Ablatherm.

    Ablatherm also utilizes a patient movement detector. If the patient moves, even slightly, during treatment, treatment automatically stops until the surgeon has a chance to make adjustments accordingly. This helps protect against human error during treatment and even small movements that can affect the outcome.

    The Ablateherm’s HIFU probe support is a fully robotic device. Once it is inserted into the rectum, the device uses its own technology to deliver the treatment as mapped out by the surgeon, thus further eliminating the risk of human error.

    These benefits, combined with the low risks associated with HIFU, are the reasons why we are proud to offer it in our clinic. Call us today to schedule a consultation to discuss HIFU using t

    Sentiment: Strong Buy

  • Item 4. Ownership.

    (a) Amount beneficially owned: 1'290'000.

    (b) Percent of class: 5%.

    Sentiment: Strong Buy

  • Reply to

    Big difference in price

    by stingersam1 Mar 30, 2016 8:40 AM
    termi0209 termi0209 Mar 30, 2016 9:44 AM Flag

    There was a trade of 58 shares at 4,31 in last second, fot this reason yahoo showed 4,31, but the close was at 4,22, because a trade with less than 100 shares means nothing.
    You can see all the trades in freerealtime ( times&sales).

    Sentiment: Strong Buy

EDAP
3.05-0.06(-1.93%)Jun 24 4:00 PMEDT